SUMMARY Sera from 271 patients with systemic rheumatic diseases were screened for antinucleolar antibodies using immunofluorescence. Antinucleolar antibodies were found in the sera of 73% of patients with progressive systemic sclerosis, 4% of patients positive for autoantibodies with rheumatoid arthritis, and 8% of patients with rheumatoid arthritis associated with sicca complex, but not in patients with systemic lupus erythematosus, Sjogren's syndrome, undifferentiated connective tissue disease, or in healthy donors. The antinucleolar sera (n=20) were analysed by immunoblotting techniques. In four sera antibodies against nucleolar proteins with molecular weights of 35 kD, 37 kD, 69 kD, 92-93 kD, and 93 kD could be immunodetected. The nucleolar autoantigens were extractable from the nucleoli together with the preribosomal particle fraction and could be solubilised by ribonuclease (RNAse) treatment. Their presence in the nucleolus was sensitive to actinomycin D treatment of cells. The 37 kD autoantigen could be identified as nucleolar phosphoprotein B23.
Patients and methods

PATIENTS
All patients (n=271) were registered at the Staatliches Rheumakrankenhaus in Baden-Baden. The (Fig. 4b) and a 100 000 g pellet (Fig. 4c) , and the fraction of nucleolar chromatin (Fig. 4d ). This procedure did not yield a clear cut separation of nucleolar subfractions, but it was useful for obtaining preliminary information. The nucleolar subfractions were characterised by SDS-gel electrophoresis and immunoblotting using the autoimmune sera Nos 1-4 (Figs 41-IV). All identified nucleolar autoantigens were extractable with the 10 mM TRIS fraction. The 10 mM TRIS fraction was further separated into a pellet containing a preribosomal particle and a soluble supernatant by high speed centrifugation (100 000 g, 16 h). The 69 kD and 35 kD proteins ( Comparison of the nucleolar autoantigens identified in this paper with nucleolar proteins described in the literature indicated a possible identity of the 37 kD autoantigen with nucleolar phosphoprotein B23, which also has a molecular weight of 37 kD. We isolated nucleolar phosphoprotein B23 as described by Michalik et al. 21 The identity of both proteins was verified by gel electrophoresis and immunoblotting of isolated B23 (Fig. 5) , by an enzyme linked immunosorbent assay with serum No 1 and by immunofluorescence studies (Fig. 6) . After absorption of serum No 1 with isolated B23 (150 [tg/ml serum) (Fig. 6b) the ability of staining nucleoli of HeLa cells was completely abolished. All five autoantigens could be identified as proteins and were detected in the fraction containing the preribosomal particles of the nucleoli. The sensitivity of the nucleolar location of the five autoantigens to actinomycin D treatment of cells and the RNAse dependent solubility in situ lead us to the conclusion that the described autoantigens are components of the ribonucleoprotein or interact with the nucleolar ribonucleoprotein fibres.
In some earlier studies concerned with nucleolar autoantigens reacting with sera from patients suffering from rheunr3tic diseases a 4-6 S RNA was identified as the reacting component.9 Furthermore, ribonucleoprotein particles containing 7-5 S-A and 7-5 S-B RNA,23 7-2 S RNA,24 25 or U3 RNA25 have been described. Only one protein exclusively located in the nucleolus, RNA polymerase I, has been described so far to be immunoreactive with rheumatic autoimmune sera. 26 (Figs 3g and h ) and by their different distribution in the 10 mM TRIS fractions of nucleoli (Figs 4111 and IV) . One of them, however, may be identical with a 94 kD nucleolar protein also associated with ribonucleoprotein fibres.28 To our knowledge nucleolar proteins analogous to our 35 kD and 69 kD nucleolar autoantigens (serum No 2) have not yet been characterised. Our data concerning the corelation with clinical diagnosis and the frequency of expression of antinucleolar antibodies, which was especially high (73%) in patients with PSS, are essentially in accordance with other reports.7 8 It is noteworthy that despite the fact that 8/11 autoimmune sera of patients with PSS showed positive nucleolar immunofluorescence only 1/11 autoimmune sera reacted with nucleolar components after SDS-gel electrophoresis. This may be due to SDS sensitive epitopes or to epitopes present on RNA which do not bind to nitrocellulose under the conditions used. On the basis of these findings it is necessary to include other autoantigens, such as scl-70 and centromere,2 into molecular immunodiagnostics of PSS. The identified nucleolar autoantigens represent a promising basis for further investigations of the specific cellular functions of autoantigens, which might help to elucidate the aetiologies of autoimmune disease.
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